title: Reply to Kremer M et al., the JAK2 V617F mutation occurs frequently in myelodysplastic/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis.
authors.forename: K
authors.initials: K
authors.lastname: Ohyashiki
authors.forename: J H
authors.initials: JH
authors.lastname: Ohyashiki
mesh_terms: D003937:Diagnosis, Differential; D005355:Fibrosis; D005819:Genetic Markers; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D009190:Myelodysplastic Syndromes / Q000235:genetics* / Q000473:pathology*; D009196:Myeloproliferative Disorders / Q000235:genetics / Q000473:pathology; D017354:Point Mutation; D055728:Primary Myelofibrosis / Q000235:genetics* / Q000473:pathology*
chemical_list: D005819:Genetic Markers; C507924:JAK2 protein, human; D053614:Janus Kinase 2